NIAID performs and sustains scientific trials evaluating therapies and vaccine candidates versus serious acute respiratory disorder coronavirus type 2, the virus that causes COVID-19. Colorized framework of a model for universal influenza vaccine. The nanoparticle is a hybrid of a protein scaffold and eight influenza hemagglutinin proteins externally. The hemagglutinin was specifically crafted to present antibody binding sites common to all human flu subtypes. NIAID is sustaining and performing research to locate better and new methods to identify, protect against and treat influenza infection.
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions
** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.